RNXT
RenovoRx Inc
1.30$
-2.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +358.1% | +114.2% | -37.0% | -10.5% | +136.6% | +61.5% | – | |
| – | – | – | – | – | – | – | -20.0% | -25.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | +61.7% | -65.1% | -47.2% | +200.0% | +70.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +162.1% | -21.1% | -1.4% | +128.1% | +59.9% | – | |
| – | -50.1% | +80.8% | -37.8% | +40.5% | -15.6% | +43.1% | +43.5% | +17.1% | +7.8% | -39.1% | -8.3% | +72.4% | +43.9% | -15.4% | -52.4% | +62.2% | +22.7% | +7.0% | -4.5% | +4.2% | -13.2% | +18.2% | -10.9% | -18.2% | -2.3% | – | |
| – | -19.4% | -8.5% | +2.2% | +123.5% | -21.1% | +90.3% | +99.8% | +36.7% | -28.7% | +7.4% | +6.0% | +37.9% | -24.6% | -6.6% | -26.0% | +21.7% | +22.4% | -21.0% | -6.7% | +42.9% | -3.1% | +13.5% | -9.1% | +73.1% | +7.2% | – | |
| – | -42.8% | +51.2% | -29.8% | +64.8% | -17.8% | +61.1% | +68.9% | +27.5% | -13.0% | -17.3% | +0.4% | +50.3% | +3.5% | -11.6% | -40.4% | +39.3% | +22.5% | -6.8% | -5.4% | +20.1% | -8.2% | +15.8% | +9.4% | +5.8% | +0.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +8.8% | +26.3% | -2.1% | +72.6% | -47.6% | +10.1% | -99.6% | +1,900.0% | +10.0% | +59.1% | -88.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +2,275.0% | -50.5% | -295.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.